Bio-Modeling Systems: The Mechanisms-Based Mecidicine Company
  • 2017: PRESS-RELEASE: Paris-November 16, 2017:BMSystems is selected to pitch at the “Translational Neurosciences Conference” organized by “NeurATRIS” and supported by “eartis” the European Infrastructure For Translational Medicine, comprising more than 80 leading European Institutes.

  • 2017: PRESS-RELEASE: Paris-New-York October 4, 2017: BMSystems, with its 14 independently validated successes to date, is selected by the Galien Foundation for the MedStartUp Award 2017 program first step during the US Galien Prize Forum in New-York.
     
  • 2017: ANNOUNCEMENT: Latest news:  Press-release from Hospices Civils de Lyon about phage therapy success with Pherecydes Pharma bacteriophages. Pherecydes-Pharma, is BMSystems’ first therapeutic spin-off.
     
  • 2017: ANNOUNCEMENT: Paris September 7, 2017: The future of Medicine: Bio-Modeling Systems invited to present at the Summer Universities of Fédération Hospitalière de France
     
  • 2017: ANNOUNCEMENT: Belgium August 26-27, 2017: BMSystems selected to meet Wallonia life Sciences Companies and is invited to the Spa-Francorchamps Formula 1 Race. Great place for top meeting!

  • 2017: ANNOUNCEMENT: Paris July 4, 2017. BMSystems was invited to present at the Conference INSEAD Alumni at BCG Paris Office: Everything you always wanted to know about Digital Health revolution “big promises” but were afraid to ask!

  • 2017: ANNOUNCEMENT: Paris January 17, 2017: BMSytems was invited at the France-India healthcare Summit to present its Computer Augmented Deductive Intelligence platform and its operational successes

  • 2017: ANNOUNCEMENT: Paris January 17, 2017: BMSytems invited to present its collaborative success story with CEA life Sciences at the 10 years anniversary of Medicen Paris Region Health cluster

  • 2017: Happy New Year: Our 8 Resolutions for 2017 to be ready for the upcoming bubble explosion! - Bonne Année: Nos 8 Résolutions pour 2017
     
  • 2016: INTERVIEW (Post LinkedIn FR avec explications): "Drug Discovery and health Big Data. The enormous Bubble will explode.” (Post LinkedIn ENG with all the explanations)  Manuel GEA, CEO of BMSystems in Biotech & Finances the leading biotech sector information letter

  • 2016: ANNOUNCEMENT: Paris October 5, 2016: BMSystems' CEO invited to present its digital-biology strategy and achievements at the inaugural session of Medicen Paris Region 10th years anniversary

  • 2016: PRESS RELEASE: Paris September 5, 2016: BMSystems selected to present CADI Discovery at the Connexion R&D conference organized by COSMETIC-VALLEY the leading Perfumery & Cosmetic cluster in France.

  • 2016: ANNOUNCEMENT August 1, 2016: BIO-MODELING SYSTEMS' novel Parkinson's therapy mentioned in a Report Covering 179 Companies. A new recognition of CADI Discovery capability to generate novel therapeutic strategies in complex human diseases of which CNS

  • 2016: Updated: Inaugural Presentation Bio-Entrepreneur 2015: The future will be digital and biology, but who will lead? Google? Watson? Alone or MDs, Physiologists, Biologists educating and mastering them combining diagnostics, therapies, connected devices and IT technologies?
Bio-Modeling Systems: The Mechanisms-Based Mecidicine Companys

BMSystems collaborative Network

BMSystems collaborative scientific and business network (past, present non-confidential extract)

  • Pharma companies: (confidential).
  • Cosmetic companies: (confidential).
  • Biotech, Medical devices, Diagnostic companies: (Confidentail)
  • CEA Life Sciences: CEA iMETI [Institute of emerging diseases and innovative therapy]  France
  • Persistent Systems Pune India
  • Persisent Systems SAS (France)
  • Max Planck Institute of Psychiatry of Munich Germany.
  • Ludwig Maximilian University Neuro-cognitive psychology of Munich Germany
  • Fondation FondaMental (Scienctific cooperation foundation) Mental illnesses France
  • University of Milan Milan Italy
  • Kayentis: The provider of the first "Digital Pen and Paper technology  2.0", the universal platform delivering "contextualized" information.
  • BioPhys-Solutions: Pioneer in innovative physical formulation of biotechnological products
  • Biocitech: Technology Park.
  • Pherecydes-Pharma: Our first spin-off. Antibacterial agents
  • Amarokbiotech: Synthon's program partner
  • ARD: (Agro-industries Research & Development) leading Industrial Biotech research company in the industrial biotech world class cluster in France.
  • IBT: (Troyes Institute of Biotechnologies). Technological transfer institute.
  • CVG: Chemistry company based in Picardie for "green" sourcing research.
  • L'Oréal: World leader in the cosmetic market. Synthon's program partner.
  • Rhodia: Major actor in the fine chemicals market (former Aventis fine chemical business). Synthon's program partner.
  • Arkema: Major actor in the chemistry market (former Total chemical business) Synthon's program partner
Bio-Modeling Systems: a leading Integrative Heuristic Systems Biology / Predictive Integrative Biology Mechanisms-Based Medicine company that delivers